ERAP1 promotes Hedgehog-dependent tumorigenesis by controlling USP47-mediated degradation of βTrCP.

Nat Commun 2019 07 24;10(1):3304. Epub 2019 Jul 24.

Department of Molecular Medicine, University La Sapienza, 00161, Rome, Italy.

The Hedgehog (Hh) pathway is essential for embryonic development and tissue homeostasis. Aberrant Hh signaling may occur in a wide range of human cancers, such as medulloblastoma, the most common brain malignancy in childhood. Here, we identify endoplasmic reticulum aminopeptidase 1 (ERAP1), a key regulator of innate and adaptive antitumor immune responses, as a previously unknown player in the Hh signaling pathway. We demonstrate that ERAP1 binds the deubiquitylase enzyme USP47, displaces the USP47-associated βTrCP, the substrate-receptor subunit of the SCF ubiquitin ligase, and promotes βTrCP degradation. These events result in the modulation of Gli transcription factors, the final effectors of the Hh pathway, and the enhancement of Hh activity. Remarkably, genetic or pharmacological inhibition of ERAP1 suppresses Hh-dependent tumor growth in vitro and in vivo. Our findings unveil an unexpected role for ERAP1 in cancer and indicate ERAP1 as a promising therapeutic target for Hh-driven tumors.

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41467-019-11093-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6656771PMC
July 2019
2 Reads
10.742 Impact Factor

Publication Analysis

Top Keywords

erap1
6
βtrcp degradation
4
innate adaptive
4
regulator innate
4
adaptive antitumor
4
tumor growth
4
hh-dependent tumor
4
suppresses hh-dependent
4
immune responses
4
promotes βtrcp
4
antitumor immune
4
key regulator
4
growth vitro
4
identify endoplasmic
4
degradation events
4
vivo findings
4
childhood identify
4
pathway enhancement
4
endoplasmic reticulum
4
vitro vivo
4

Similar Publications